Follow The Filings

OMCL Omnicell

Omnicell earnings company data as of 8:01 PM ET 10/22

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 29 Oct EPS 0.24 — —
Rev — — —

Insider trades

Open-market buys and sales by OMCL's executives, directors and 10% owners in the last 12 months, from their Form 4s

All OMCL insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • $3M sold by 3 insiders under 10b5-1 plans
  1. Nnamdi Njoku COO
    Planned sale
    $114K 3,083 shares at $36.85 1.9% of stake
    Traded Aug 17 Filed Aug 18
  2. Randall A Lipps CEO
    Planned sale
    $470K 10,000 shares at $47.00 2.8% of stake
    Traded Jul 15 Filed Jul 17
  3. Nnamdi Njoku COO
    Planned sale
    $134K 3,090 shares at $43.22 2% of stake
    Traded May 18 Filed May 19
  4. Corey J Manley EVP&Chief Legal/Admin Officer
    Planned sale
    $217K 5,025 shares at $43.22 4.3% of stake
    Traded May 18 Filed May 19
  5. Corey J Manley EVP&Chief Legal/Admin Officer
    Planned sale
    $257K 7,405 shares at $34.69 7.1% of stake
    Traded Mar 16 Filed Mar 17
  6. Corey J Manley EVP&Chief Legal/Admin Officer
    Planned sale
    $155K 4,243 shares at $36.59 4.7% of stake
    Traded Feb 17 Filed Feb 18
  7. Corey J Manley EVP&Chief Legal/Admin Officer
    Planned sale
    $305K 6,106 shares at $49.90 6.2% of stake
    Traded Jan 8 Filed Jan 12
  8. Corey J Manley EVP&Chief Legal/Admin Officer
    Planned sale
    $12K 278 shares at $43.30 0.3% of stake
    Traded Dec 16, 2025 Filed Dec 17, 2025
  9. Corey J Manley EVP&Chief Legal/Admin Officer
    Planned sale
    $244K 6,106 shares at $39.90 5.8% of stake
    Traded Dec 3, 2025 Filed Dec 5, 2025
  10. Randall A Lipps CEO
    Planned sale
    $1M 28,250 shares at $35.97 6.8% of stake
    Traded Dec 1, 2025 Filed Dec 3, 2025
  11. Corey J Manley EVP&Chief Legal/Admin Officer
    Planned sale
    $121K 3,473 shares at $34.90 3.2% of stake
    Traded Nov 17, 2025 Filed Nov 18, 2025

Also filed in the last 12 months, not counted as buying or selling: 21 share withholdings for taxes, 18 stock grants, and 1 option exercise.

SEC filings

Recent issuer filings from EDGAR, 14 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01
8-K 5.02,9.01
8-K 5.02,5.03,5.07,9.01
SCHEDULE 13G —
10-Q
SCHEDULE 13G —
SCHEDULE 13G —
8-K 2.02,9.01
DEF 14A
SCHEDULE 13G —
SCHEDULE 13G/A —
10-K

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.